​
​

Solid Biosciences (SLDB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Solid Biosciences Revenue Highlights

00

Solid Biosciences Revenue by Period

Solid Biosciences Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$8.09M-40.57%
2021-12-31$13.62M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Solid Biosciences generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Solid Biosciences Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$4.74M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$8.09M100.00%
2022-09-30--100.00%
2022-06-30$6.17M220.47%
2022-03-31$1.93M-38.97%
2021-12-31$3.15M-10.83%
2021-09-30$3.54M-1.59%
2021-06-30$3.59M7.77%
2021-03-31$3.33M-96.61%
2020-12-31$98.32M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31--

Solid Biosciences generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Solid Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALECAlector$97.06M$15.08M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
MOLNMolecular Partners$7.04M$2.74M
IPSCCentury Therapeutics$2.23M$791.00K
BCELAtreca$770.00K$80.00K
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
BDTXBlack Diamond Therapeutics--
CCCCC4 Therapeutics--
CABACabaletta Bio--
PASGPassage Bio--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
LRMRLarimar Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
SLDBSolid Biosciences--
EWTXEdgewise Therapeutics--

SLDB Revenue FAQ

What is Solid Biosciences’s yearly revenue?

Solid Biosciences's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $8.09M, representing a decrease of -40.57% compared to 2021. SLDB's yearly revenue for 2021 was $13.62M, representing an increase of 100.00% compared to 2020.

What is Solid Biosciences’s quarterly revenue?

Solid Biosciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). SLDB's quarterly revenue for Q4 2023 was $4.74M, a 100.00% increase from the previous quarter (Q3 2023), and a -41.49% decrease year-over-year (Q4 2022).

What is Solid Biosciences’s revenue growth rate?

Solid Biosciences's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.